Photo by: PHIL NOBLE
Credit: REUTERS
Your correspondent, Harriet McLea confuses type 1 diabetes and type 2 in the whole article. As a professional journalist, she should be aware of the difference between the two. This is not rocket science. Not your journal employs sub-editors to verify these things?
"Inject insulin from five times a day", as no Member States McLea is the scheme of type 2 diabetes, as someone could tell you (myself included). This was the payload for type 1 diabetics, which typically develop the problem in early childhood or youth. It is less common than type 2, which is reaching epidemic proportions in the Western world.
Whereas type 1 is a malfunction in the pancreas, type 2 is usually caused by lack of exercise, poor diet and lifestyle issues.
The writer does not explain what is meant by "long-acting insulin. This makes reference to insulin "patches" or a completely new drugs, so far not developed?
More important are the new implications of stem cell therapy for diabetes, still some time away, but certainly a hope for the future.
0 komentar:
Posting Komentar